phase 3_completion
saveMashhad University of Medical Sciences — acetazolamide (Phase III Trial Completion)
community read0 votes
Therapy area: Central Nervous System. Indication: Epilepsy
Data sources
globaldata
Found something off?
drug timeline · 8
- approvalACETAZOLAMIDE — FDA approvalApr 2, 2026 · 187d ago
- approvalACETAZOLAMIDE — FDA approvalApr 2, 2026 · 187d ago
- approvalACETAZOLAMIDE — FDA approvalApr 2, 2026 · 187d ago
- approvalACETAZOLAMIDE — FDA approvalJan 12, 2026 · 267d ago
- approvalACETAZOLAMIDE — FDA approvalJan 8, 2026 · 271d ago
- approvalACETAZOLAMIDE — FDA approvalJan 8, 2026 · 271d ago
- approvalACETAZOLAMIDE — FDA approvalJan 8, 2026 · 271d ago
- approvalACETAZOLAMIDE — FDA approvalSep 16, 2025 · 385d ago
🐶 often sniffed alongside
top 8- tagApproval128 co-mentions · 64 sources
- drugacetazolamide ER65 co-mentions · 65 sources
- drugacetazolamide PR65 co-mentions · 65 sources
- tagSmall Molecule64 co-mentions · 64 sources
- companyMankind Pharma Ltd5 co-mentions · 5 sources
- companyNovitium Pharma LLC4 co-mentions · 4 sources
- companyStrides Pharma Inc4 co-mentions · 4 sources
- companyAjanta Pharma Ltd3 co-mentions · 3 sources
comments(0)
5-min edit window · permanent after that